Phase 1 Study of Prevention of Cardiac Device Replacement Site Infection
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Infection
- Sponsor
- Yong Seog Oh
- Enrollment
- 352
- Locations
- 1
- Primary Endpoint
- freedom of cardiac device-related infection
- Status
- Recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
Cardiovascular implantable electronic device (CIED) infections have been increasing out of proportion to the number of devices implanted the investigators investigated recent trends and possible causes of the increasing numbers of Cardiovascular implantable electronic device infections.
Detailed Description
There are many studies on the preventive use of Antibiotics or povidone iodine to Cardiovascular implantable electronic device (CIED) infections. But, studies of posterior pocket capsule removal is still limited. The investigators had planned research on effects of posterior pocket capsule removal before cardiac devices replacement.
Investigators
Yong Seog Oh
Ph.D
Seoul St. Mary's Hospital
Eligibility Criteria
Inclusion Criteria
- •scheduled for cardiac devices replacement
Exclusion Criteria
- •under the age of 18
- •take an antibiotic
- •history of infection within 30 days
Outcomes
Primary Outcomes
freedom of cardiac device-related infection
Time Frame: 1 year after precedure
check the symptoms of infection. If have symptoms of infection : check the fever, heart rate, respiration rate, blood test, EKG
Secondary Outcomes
- freedom of endocarditis(1 year after precedure)